Last edition
News about "Aruka Bio investment"
Cohance Lifesciences Advances its ADC Strategy Investment of USD 18 million in NJ Bio and Aruka Bio
Cohance Lifesciences invests USD 18 million in NJ Bio and Aruka Bio to strengthen its ADC strategy, customer services and proprietary pipeline development.
Aruka Bio Investment | 04/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members